Objectives: After traumatic brain injury, continuous electroencephalography is widely used to detect electrographic seizures. With the development of standardized continuous electroencephalography terminology, we aimed to describe the prevalence and burden of ictal-interictal patterns, including electrographic seizures after moderate-to-severe traumatic brain injury and to correlate continuous electroencephalography features with functional outcome. Design: Post hoc analysis of the prospective, randomized controlled phase 2 multicenter INTREPID 2566 study (ClinicalTrials. gov: NCT00805818). Continuous electroencephalography was initiated upon admission to the ICU. The primary outcome was the 3-month Glasgow Outcome Scale-Extended. Consensus electroencephalography reviews were performed by raters certified in standardized continuous electroencephalography terminology blinded to clinical data. Rhythmic, periodic, or ictal patterns were referred to as "ictal-interictal continuum"; severe ictal-interictal continuum was defined as greater than or equal to 1.5 Hz lateralized rhythmic delta activity or generalized periodic discharges and any lateralized periodic discharges or electrographic seizures. Setting: Twenty U.S. level I trauma centers. Patients: Patients with nonpenetrating traumatic brain injury and postresuscitation Glasgow Coma Scale score of 4-12 were included. Interventions: None. Measurements and Main Results: Among 152 patients with continuous electroencephalography (age 34 ± 14 yr; 88% male), 22 (14%) had severe ictal-interictal continuum including electrographic seizures in four (2.6%). Severe ictal-interictal continuum burden correlated with initial prognostic scores, including the International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (r = 0.51; p = 0.01) and Injury Severity Score (r = 0.49; p = 0.01), but not with functional outcome. After controlling clinical covariates, unfavorable outcome was independently associated with absence of posterior dominant rhythm Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (http://journals.lww.com/ ccmjournal).
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Dr. Moseley's institution received funding from Neuren Pharmaceuticals (for the INTREPID trial in traumatic brain injury, during which this electroencephalography data were obtained), LivaNova, Sunovion, GW Pharma, and Nonin Medical Inc., NYU, and he received funding from LivaNova, Eisai, UCB, and Validus Pharmaceuticals. Dr. Privitera received funding from Sage. Dr. Foreman's institution received funding from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; and he received funding from UCB Inc. Speakers Bureau. (1) . After moderate-tosevere TBI, neurologic outcome prediction is critical to clinicians and families. Prognostic models employ admission clinical assessments such as the Glasgow Coma Scale (GCS), pupillary reactivity, and CT findings to predict long-term outcome (2) (3) (4) (5) . The International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) model was validated across more than 15,000 patients and exhibits an area under the curve (AUC) between 0.66 and 0.84 (4). However, predictive models such as IMPACT do not include information regarding brain function nor provide a dynamic assessment over time, precluding assessment of the impact of secondary brain injuries.
Continuous Electroencephalography After
Continuous EEG (cEEG) monitoring has been recommended for patients with acute brain injury and altered mental status to detect electrographic seizures (ESz) (6) . ESz have been reported in 18-33% of adult patients with moderate-tosevere TBI (6) and are associated with secondary brain injury, which may impact outcome (7) (8) (9) (10) . However, some periodic or rhythmic patterns may not meet agreed upon definitions of ESz, and the terminology to describe these patterns, which lie along an ictal-interictal continuum (IIC), has been recently standardized (11) . There are little prospective data leveraging cEEG to identify ESz, and the occurrence of IIC patterns has not been quantified in adults following TBI. Further, a small number of studies describing background reactivity (12) , variability (13) , and the presence of sleep architecture (14) (15) (16) (17) have suggested that EEG data contain prognostic information following TBI, but the importance of early cEEG information in the context of established clinical predictors is unknown.
We performed a post hoc analysis of a prospective, multicenter randomized clinical study of moderate-to-severe TBI with two objectives: 1) to assess the prevalence, characteristics, and predictors of abnormal cEEG features including ESz and 2) to determine whether specific cEEG features were predictive of 3-month functional outcome after controlling for clinical variables.
METHODS

Subjects
We performed a post hoc analysis of the INTREPID 2566 study (ClinicalTrials.gov: NCT00805818), a multicenter randomized, controlled phase 2 clinical trial conducted April 2010 to January 2016 at 20 U.S. centers to evaluate the safety and efficacy of glycyl-L-2-methylprolyl-L-glutamic acid (NNZ-2566) in patients with moderate-to-severe TBI. NNZ-2566, a synthetic analog of a naturally occurring neurotrophic peptide derived from insulin-like growth factor-1, demonstrated neuroprotective efficacy and reduced injury-induced seizures in rat models (18) . INTREPID 2566 failed to demonstrate significant differences in either adverse events or global outcome, measured by the Glasgow Outcome Scale-Extended (GOSE). Study participants included those 18-70 years old with nonpenetrating TBI, postresuscitation GCS score of 4-12, postresuscitation hemodynamic stability, and able to randomize to study drug or placebo within 8 hours of injury. Exclusion criteria were spinal cord injury, significant bodily coinjuries, prior brain injury requiring hospitalization, severe comorbidities, weight greater than 150 kg, fluid resuscitation greater than 6 L prior to randomization, and those at-risk for QT prolongation.
The INTREPID 2566 study was approved by the Institutional Review Board at each participating institution. Written informated consent was obtained from all patients or their legal surrogates.
Data Collection
The trial protocol included bedside cEEG initiated upon admission to the ICU and continued at least through the 72-hour maintenance drug infusion. cEEG was not performed in some patients who required immediate neurosurgical intervention, whose family members withdrew life-sustaining treatments, or who were admitted while sites were not yet validated for cEEG. Thirteen scalp electrodes were positioned based on the International 10-20 System: Fp1, F7, C3, T3, T5, O1, Cz, Fp2, F8, C4, T4, T6, and O2. Clinical features were collected including demographics, TBI-specific variables (i.e., injury description, Injury Severity Score [ISS], CT classification within the first 24 hr), neurologic examination findings (i.e., postresuscitation GCS, pupillary reactivity), the use of sedative agents and antiseizure drugs (ASDs), and 3-month GOSE, an eight-point ordinal functional outcome scale. posterior dominant rhythm (PDR), background fast activity, and discontinuity (simplified as > 10% of the record consisting of attenuation or suppression). Sleep was stratified as the presence of normal (based on published criteria [21] ) or rudimentary N2 sleep transients (K complexes and/or sleep spindles), or their absence (17) . Background EEG classifications are summarized in Table 1 and Figure 1 (19, 22) . IIC patterns were classified according to their potential association with seizure activity or neuronal injury according to recent evidence (Table 1 and Fig. 2 ) (19) . ESz were defined as any spikes, sharp waves, or sharp-andslow wave complexes with a frequency greater than 2.5 Hz lasting for 10 seconds or any rhythmic or periodic discharges (i.e., IIC patterns) with clear evolution in frequency, morphology, or location (20) . Severe IIC was defined as greater than or equal to 1.5 Hz lateralized rhythmic delta activity (LRDA) or generalized periodic discharges (GPDs) and any lateralized periodic discharges (LPDs) or ESz. Finally, we calculated the IIC "burden" based on IIC prevalence and frequency (e.g., if 1.5-Hz periodic discharges were detected for 50% of an 8-hr record, then 25% of the next 24-hr, the IIC duration would be 4-hr + 6-hr = 10-hr, and the IIC burden would be 1.5-Hz × 10-hr = 15 Hz-hr) and adjusted for recording duration (11) . Because of the small sample size in the severe background and severe IIC categories, moderate and severe groups were combined for primary outcome analysis.
Electroencephalographic Review
Statistical Analysis
Data were analyzed using R (Version 3.4.3: R Core Team, Vienna, Austria) and GraphPad Prism (Version 7.03: GraphPad Software, San Diego, CA). Statistical data were summarized as mean ± sd or median (interquartile range) where appropriate. Functional outcome was dichotomized as unfavorable (GOSE 1-4; death, unresponsive wakefulness, or severe disability) or favorable (GOSE 5-8; moderate disability or good recovery). Univariate analysis was conducted using chi-square or Fisher exact tests and independent sample t tests as appropriate. Correlation between continuous variables was assessed using Pearson's correlation coefficient. All tests were two-sided with significance considered at p value of less than 0.02 to account for multiple comparisons. A proportional odds logistic regression model was constructed to evaluate independent predictors of the ordinal 3-month GOSE including the IMPACT core linear predictor, calculated using age, GCS motor score, and pupillary reactivity, in order to leverage the larger sample size used to derive this predictor (4, 23) . Significant cEEG variables associated with unfavorable outcome were individually added to the model to generate common odds ratios (ORs) and 95% CIs. Study drug treatment allocation was incorporated to exclude the impact of study drug. cEEG features were assessed for sensitivity, specificity, and AUC based on receiver operating characteristic curves and compared with the IMPACT core model.
RESULTS
Patient Characteristics
Overall, 261 patients with moderate-to-severe TBI were enrolled in the INTREPID 2566 study. cEEG was performed in 155 of 261 patients (59%). Table 2 shows the overall patient characteristics and differences between those undergoing cEEG versus those without cEEG. Of those undergoing cEEG, three patients were excluded based on inadequate cEEG quality, yielding 152 patients with 10,405 hours of cEEG for this study. The mean age of these 152 patients was 34.5 ± 14.8 years, and 134 of 152 (88%) were male. The median admission GCS score was 7 (6) (7) (8) , and the median ISS was 24 (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) cEEG Findings IIC patterns were observed in 74 of 152 patients (49%). LPDs, GPDs, and LRDA patterns were recorded in nine of 152 patients (5.9%), eight of 152 patients (5.2%), and 18 of 152 patients (12%), respectively. Severe IIC was seen in 22 of 152 patients (14%), of whom four (2.6%) had ESz. Severe IIC occurred within less than or equal to 4 hours of cEEG initiation in seven Multivariate analysis demonstrated an independent association between unfavorable outcome and the absence of PDR (OR, 3.38; 95% CI, 1.30-9.09), the absence of N2 sleep transients (OR, 3.69; 95% CI, 1.69-8.20), or the presence of predominant background delta activity (OR, 2.82; 95% CI, 1.32-6.10) during the first 72 hours of cEEG recording, and either a discontinuous background (OR, 5.33; 95% CI, 2.28-12.96), or the presence of moderate-to-severe background slowing at any time of recording (OR, 3.11; 95% CI, 1.58-6.21) after adjusting for IMPACT clinical core model, ISS, intraventricular hemorrhage, GABAergic sedative administration, and study drug allocation ( Fig. 3 ; detailed results in Supplemental Tables 2-10, Supplemental Digital Content 3, http://links.lww.com/CCM/E323).
The sensitivity and specificity of the IMPACT covariates alone to predict unfavorable outcome were 79% and 44%, respectively, with an AUC of 0.649. Adding three features (absence of PDR, absence of N2 sleep transients, and predominant background delta activity) during the first 24 hours of cEEG to the IMPACT covariates resulted in a sensitivity and specificity for unfavorable outcome of 94% and 49%, with an AUC of 0.768. The presence of these features (a PDR, N2 sleep transients, and predominantly theta or alpha background) within 72 hours predicted good outcome with a specificity of 96% and positive predictive value of 86%, but only 28% sensitivity.
DISCUSSION
In this post hoc analysis of a randomized, controlled trial of patients with moderate-to-severe TBI, we found severe IIC patterns, including ESz, in 14%. The burden of these patterns was associated with disease severity but not functional outcome at 3 months. We determined that cEEG background characteristics including PDR, N2 sleep transients, predominant background frequency, and continuity were independently associated with functional outcome at 3 months. In our cohort, the addition of cEEG variables observed within the first 24 and 72 hours of recording increased the predictive ability of the IMPACT core predictor variables.
Ours is the largest study of patients with TBI specifically focusing on scalp cEEG interpreted using ACNS' Standardized Critical Care EEG Terminology. The prevalence of both LPDs (9/152; 5.9%) and GPDs (8/152; 5.2%) were similar to previous reports, whereas LRDA was recorded in 12% of patients (18/152), which is higher than that reported in previous studies (4.7-7 .1% in general ICU population) (24) (25) (26) . We found fewer seizures, only four of 152 (2.6%), compared with previous reports (18-33%) (7, 26, 27) , which may be related to the fact that 88% of patients received ASDs (28) or that cEEG was not performed in 41% of patients, many of whom were excluded due to anticipated mortality or withdrawal of life-sustaining therapy decisions. Alternatively, patterns we described as severe IIC may have been interpreted clinically as ESz in studies conducted prior to the establishment of standardized terminology. This distinction may be of questionable clinical significance since both IIC patterns and seizures can create similar physiologic abnormalities in the setting of acute brain injuries (10, 29) .
Despite increasing evidence to suggest an association between severe IIC, clinical seizures (19, 25, 30, 31) and pathophysiologic correlates of secondary brain injury (10, 32, 33) , it remains unclear whether or not these patterns have "independent" predictive value with regard to outcome. Periodic discharges have been shown to be an independent predictor for unfavorable outcome in some populations (29, 34) , but not in others (25, 35) . Our study included a specific TBI population with a small sample size of patients with severe IIC, which may have underpowered our results despite the use of a continuous estimate of severe IIC, termed the IIC burden. Other outcome endpoints, such as cognitive measurements, may be more relevant considering the potential for severe IIC to disinhibit excitatory pyramidal cells (36) and increasing evidence for the impact of interictal epileptiform discharges on cognition in patients with epilepsy (37, 38) . Interestingly, the burden of severe IIC was positively correlated with admission injury severity, which suggests that the clinical and pathophysiologic significance of IIC patterns may be related to or modulated by underlying brain and even systemic injuries, and vice versa. This has been suggested in patients with SAH in whom inflammatory pathways have been linked with both ESz and outcome (39) . Conclusions about IIC patterns in the population evaluated in this study may not apply to the general critical care population, however. We examined the cEEG background, a reflection of underlying brain function, and our findings are consistent with those of previous studies examining reactivity (12) , variability (13) , sleep (15) (16) (17) , and dominant background frequency (40) after TBI. However, in most studies, predictors were investigated as isolated phenomena using retrospectively collected data. One study suggested a weighted dichotomous score to summate individual EEG predictors (i.e., background frequency, asymmetry, reactivity, variability, and additional patterns including epileptiform activity) and found this correlated with discharge GOSE in 57 TBI patients (41) . Although this numeric score provided an objective tool for EEG review, the method of weighting each variable was arbitrary, and major clinical confounders were not controlled. We found that a moderate-tosevere background slowing pattern at any time during cEEG was associated with unfavorable functional outcome even after controlling for established clinical variables.
Since TBI involves dynamic pathophysiology that evolves in time (42) (43) (44) , we investigated whether development or loss of specific cEEG features over time associated with outcome.
Interestingly, the absence of PDR for 24 hours had a "higher" OR for unfavorable outcome than the absence of PDR for 72 hours, whereas both the absence of N2 sleep transients and delta activity exhibited increasing ORs over time. This may be explained by a time-dependent loss of PDR in patients with moderate-to-severe TBI or a decrease in statistical power as the number of patients monitored fell (i.e., n = 139 for 24 hr vs n = 96 for 72 hr). By combining cEEG background features, we found that the addition of either 24-hour or 72-hour cEEG predictors to the core clinical IMPACT predictor model increased its AUC from 0.64, which is traditionally interpreted as poorly accurate (0.60-0.70), to 0.76, or moderately accurate (0.70-0.90) (45) . Therefore, information gained from cEEG as early as 24 hours after initiation might warrant incorporation into clinical prediction models.
Our study used data post hoc from a study that was not necessarily powered to answer the questions raised by our hypothesis. We estimate that 298 subjects per group would be required to demonstrate a significant association between severe IIC burden and unfavorable outcome at 80% power using our p value threshold. Further, only 59% of enrolled participants (155/261) underwent cEEG despite study protocol, which may have biased our sample. Patients with cEEG appeared to have more severe injury compared with those without; however, surgery and withdrawal of life-sustaining measures were reasons that patients were excluded from cEEG. Both groups had similar ISS. The number of patients with cEEG decreased over time (Supplementary Fig. 2 , Supplemental Digital Content 4, http://links.lww.com/CCM/E324; legend, Supplemental Digital Content 5, http://links.lww.com/CCM/E325), which reduced our power to make inferences about the evolution of cEEG findings and potentially led to missed ESz (26). Despite our relatively large cohort, our study sample did not allow for more precision in the categorization of background categories, sleep classification, or IIC patterns. As a result of the lack of video information and literature evidence for poor interrater agreement (46), we did not assess EEG reactivity or stimulusinduced rhythmic, periodic, or ictal discharges, which also may be important in predicting outcome after severe brain injury.
In conclusion, our data suggest that the cEEG background as early as 24 hours after initiation of the recording may provide additive prognostic information in the context of established clinical variables. We found that severe IIC patterns, while relatively common in patients with moderate-to-severe TBI, were not associated with functional outcome at 3 months although further studies are warranted to understand the effects of severe IIC patterns on more refined outcome measures such as cognition.
